Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury
- 1 February 1996
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 43 (3) , 289-298
- https://doi.org/10.1002/(sici)1097-4547(19960201)43:3<289::aid-jnr4>3.0.co;2-f
Abstract
Oligodendrocytes (OLs) and their myelin membranes are the apparent injury targets in the putative human autoimmune disease multiple sclerosis. The basis for this selective injury remains to be defined. OLs in vitro have been shown to be susceptible to both tumor necrosis factor (TNF) and non-TNF-dependent immune effector mechanisms. The former involves initial nuclear injury (apoptosis); the latter, when mediated by activated T cells, involves initial cell membrane injury (lysis). In the current study, we determined whether human adult CNS-derived OLs could be protected from the above immune effector mechanisms by selected neurotrophic factors (CNTF, BDNF, NGF, NT-3, and NT-4/5) or cytokines demonstrated to protect from human or experimental autoimmune demyelinating diseases (β-interferon [IFN], IL-10, and TGF-β). Nuclear injury was assessed in terms of DNA fragmentation using a DNA nick-end-labelling technique; cell membrane injury was assessed by lactate dehydrogenase or chromium 51 release. MTT and cell counting assays were used to assess cell viability and cell loss, respectively. Amongst the neurotrophic factors and cytokines tested, only CNTF significantly protected the OLs from TNF-mediated injury. CNTF also protected the OLs from serum deprivation-induced apoptosis. CNTF, however, did not protect the OLs from injury induced by activated CD4+ T cells. CNTF also did not protect human fetal cortical neurons from serum deprivation or TNF-induced DNA fragmentation, nor did it protect the U251 human glioma cell line from DNA fragmentation induced by a combination of TNF and reduced serum concentration in the culture media. Our results indicate that potential protective effects of neurotrophic factors or cytokines on neural cell populations can be selective both for cell type involved and mechanism of immune-mediated injury. CNTF is the protective factor selective for nuclear-directed injury of OLs.Keywords
This publication has 44 references indexed in Scilit:
- Cytokines and Murine Autoimmune Encephalomyelitis: Inhibition or Enhancement of Disease with Antibodies to Select Cytokines, or by Delivery of Exogenous Cytokines Using a Recombinant Vaccinia Virus SystemScandinavian Journal of Immunology, 1995
- The Binding and Lysis of Target Cells by Cytotoxic Lymphocytes: Molecular and Cellular AspectsAnnual Review of Immunology, 1994
- Effects of tumor necrosis factor on inward potassium current and cell morphology in cultured human oligodendrocytesGlia, 1993
- Injury‐induced Regulation of Ciliary Neurotrophic Factor mRNA in the Adult Rat BrainEuropean Journal of Neuroscience, 1993
- Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: Synergistic effects of monosialogangliosidesJournal of Neuroscience Research, 1992
- Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytesThe Journal of Membrane Biology, 1991
- Anti—tumor necrosis factor therapy abrogates autoimmune demyelinationAnnals of Neurology, 1991
- Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFβGlia, 1991
- An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988